CLASS II Device recall · Reported 28 Aug 2019 · FDA Enforcement Report

Kit BD Max StaphSR recalled by Becton Dickinson &

Becton Dickinson & is recalling Kit BD Max StaphSR, distributed in 38 states. The recall was initiated on 17 Jul 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 9086668; ; UDI (GTIN, DI+PI) : (01)00382904434199 (17)200902(10)9086668(30)1; Exp :9/2/2020 Lot # 9092724; UDI (GTIN, DI+PI) :(01)00382904434199 (17)200902(10)9092724(30)1; Exp: 9/2/2020
Quantity recalled283 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2332-2019
FDA event ID
83406
Recalling firm
Becton Dickinson &, Sparks, MD
Classification
Class II
Status
Terminated
Recall initiated
17 Jul 2019
FDA classified
22 Aug 2019
Reported
28 Aug 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

17 Jul 2019Recall initiated by company
22 Aug 2019Classified by FDA+36 days
28 Aug 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Kit BD Max StaphSR; Catalog # 443418

Where it was distributed

AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, NH, NJ, NM, NV, NY, OH, OR, PA, PR, RI, SC, TN, TX, VA, WA, WI, WV Worldwide: Australia, Belgium, Brazil, Canada, Chile, China, Hong Kong, Japan, Korea, Mexico, Singapore, Taiwan

AlabamaArkansasArizonaCaliforniaColoradoConnecticutFloridaGeorgiaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMichiganMinnesotaMissouriMontana

Questions about this recall

Is Kit BD Max StaphSR recalled?

Yes. Becton Dickinson & recalled Kit BD Max StaphSR on 17 Jul 2019. The recall is Class II and its status is Terminated. Recall number Z-2332-2019.

Why was it recalled?

The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly.

Which lots are affected?

Lot # 9086668; ; UDI (GTIN, DI+PI) : (01)00382904434199 (17)200902(10)9086668(30)1; Exp :9/2/2020 Lot # 9092724; UDI (GTIN, DI+PI) :(01)00382904434199 (17)200902(10)9092724(30)1; Exp: 9/2/2020

Where was it sold?

AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, NH, NJ, NM, NV, NY, OH, OR, PA, PR, RI, SC, TN, TX, VA, WA, WI, WV Worldwide: Australia, Belgium, Brazil, Canada, Chile, China, Hong Kong, Japan, Korea, Mexico, Singapore, Taiwan

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson &

All 361

Other Other Medical Devices recalls

All 13,778